- Home
- MKTW vs ABVC Comparison
MKTW vs ABVC Comparison
Compare MKTW & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MKTW | ABVC |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 35.6M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MKTW | ABVC |
|---|---|---|
| Price | $17.76 | $1.45 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 25.8K | ★ 110.3K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | ★ 9.92% | N/A |
| EPS Growth | ★ 1183.33 | 7.14 |
| EPS | ★ 2.31 | N/A |
| Revenue | ★ $512,403,000.00 | $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.91 | N/A |
| P/E Ratio | $7.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.66 | $0.81 |
| 52 Week High | $21.74 | $4.02 |
Technical Indicators
Market Signals| Indicator | MKTW | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 56.57 |
| Support Level | $16.61 | $1.18 |
| Resistance Level | $20.81 | $1.67 |
| Average True Range (ATR) | 1.24 | 0.16 |
| MACD | 0.08 | 0.06 |
| Stochastic Oscillator | 53.14 | 61.49 |
Price Performance
Historical ComparisonAbout MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.